These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 3997623)

  • 21. [Role of obligate anaerobes in infections in hospitalized patients and therapeutic options].
    Wróblewska M; Rokosz A; Sawicka-Grzelak A; Kot K; Luczak M
    Med Dosw Mikrobiol; 2005; 57(2):199-208. PubMed ID: 16134392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The identification and antimicrobial susceptibility of anaerobic bacteria from pneumonic cattle lungs.
    Chirino-Trejo JM; Prescott JF
    Can J Comp Med; 1983 Jul; 47(3):270-5. PubMed ID: 6640410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
    Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
    Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010-2011.
    Marchand-Austin A; Rawte P; Toye B; Jamieson FB; Farrell DJ; Patel SN
    Anaerobe; 2014 Aug; 28():120-5. PubMed ID: 24923267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotic sensitivity of anaerobic bacteria isolated during one year (1993)].
    Durán MT; Molina F
    Enferm Infecc Microbiol Clin; 1996; 14(6):370-6. PubMed ID: 8756216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anaerobic bacterial infections and response to treatment in dogs and cats: 36 cases (1983-1985).
    Dow SW; Jones RL; Adney WS
    J Am Vet Med Assoc; 1986 Oct; 189(8):930-4. PubMed ID: 2876976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients.
    Worlitzsch D; Rintelen C; Böhm K; Wollschläger B; Merkel N; Borneff-Lipp M; Döring G
    Clin Microbiol Infect; 2009 May; 15(5):454-60. PubMed ID: 19196263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of antibiotic resistant strains of Bacteroides fragilis.
    Scher KS
    Surg Gynecol Obstet; 1988 Sep; 167(3):175-9. PubMed ID: 3413646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sensitivity of anaerobic bacteria to therapeutic agents (Zurich 1984)].
    Wüst J; Hardegger U
    Schweiz Med Wochenschr; 1985 Dec; 115(52):1886-90. PubMed ID: 4089587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study.
    Boyanova L; Vladimir Djambazov ; Gergova G; Dragomir Iotov ; Petrov D; Osmanliev D; Minchev Z; Mitov I
    Anaerobe; 2004 Oct; 10(5):261-7. PubMed ID: 16701526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of doripenem, a new broad-spectrum carbapenem, against recently collected clinical anaerobic isolates, with emphasis on the Bacteroides fragilis group.
    Snydman DR; Jacobus NV; McDermott LA
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4492-6. PubMed ID: 18838581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obligate anaerobes in clinical veterinary practice.
    Hirsh DC; Biberstein EL; Jang SS
    J Clin Microbiol; 1979 Aug; 10(2):188-91. PubMed ID: 511987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anaerobic bacteria in orofacial abscesses.
    Botha SJ; Senekal R; Steyn PL; Coetzee WJ
    J Dent Assoc S Afr; 1993 Aug; 48(8):445-9. PubMed ID: 9508939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species.
    Aldridge KE; Ashcraft D; Cambre K; Pierson CL; Jenkins SG; Rosenblatt JE
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1238-43. PubMed ID: 11257040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Susceptibility of anaerobic bacteria to antimicrobial agents.
    Collignon PJ; Munro R; Morris G
    Pathology; 1988 Jan; 20(1):48-52. PubMed ID: 3374973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clindamycin resistance in anaerobic bacteria.
    Tally FP; Cuchural GJ; Bieluch VM; Jacobus NV; Malamy MH
    Scand J Infect Dis Suppl; 1984; 43():34-43. PubMed ID: 6598519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
    Liu CY; Huang YT; Liao CH; Yen LC; Lin HY; Hsueh PR
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3161-8. PubMed ID: 18625771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anaerobic bacteria and bacterial infections: perspectives on treatment and resistance in Italy.
    Panichi G; Di Rosa R; Enrico P; Babudieri S
    Rev Infect Dis; 1990; 12 Suppl 2():S152-6. PubMed ID: 2305181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U; Manncke B; Gerbracht K; Werner H
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.